The effect of disease activity on body composition and resting energy expenditure in patients with rheumatoid arthritis

Journal of Inflammation Research

Volumn 4, Issue 1, 2011, Pages 61-66

  Binymin, K ^a,c   Herrick, A L ^a   Carlson, G L ^b   Hopkins, S J ^b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c SOUTHPORT AND ORMSKIRK HOSPITAL NHS TRUST   (United Kingdom)

Author keywords

Cachexia; Fat mass; Free fat mass; Interleukin 6; Resting energy expenditure; Rheumatoid arthritis

Indexed keywords

INTERLEUKIN 6;

ADULT; ARTICLE; BODY COMPOSITION; BODY FAT; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; DIETARY INTAKE; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE EXACERBATION; ENERGY EXPENDITURE; FEMALE; FOOD INTAKE; HUMAN; MALE; PROTEIN BLOOD LEVEL; RHEUMATOID ARTHRITIS;

EID: 79959523521     PISSN: None     EISSN: 11787031     Source Type: Journal    
DOI: 10.2147/JIR.S16508     Document Type: Article

References (34)

1. Paget J. Nervous mimicry of organic diseases. Lancet. 1873;ii: 727-729.
2. Morley JE, Thomas DR, Wilson MM. Cachexia: pathophysiology and clinical relevance. Am J Clin Nutr. 2006;83:735-743.
3. Muscaritoli M, Anker SD, Argilés J, et al. Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics". Clin Nutr. 2010;29:154-159.
4. Summers GD, Deighton CM, Rennie MJ, Booth AH. Rheumatoid cachexia: a clinical perspective. Rheumatology (Oxford). 2008;47: 1124-1131.
5. Houssiau FA, Devogelaer JP, Van Damme J, de Deuxchaisnes CN, Van Snick J. Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides. Arthritis Rheum. 1988;31:784-788.
6. Swaak AJ, van Rooyen A, Nieuwenhuis E, Aarden LA. Interleukin-6 (IL-6) in synovial fluid and serum of patients with rheumatic diseases. Scand J Rheumatol. 1988;17:469-474.
7. Giles JT, Ling SM, Ferrucci L, et al. Abnormal body composition phenotypes in older rheumatoid arthritis patients: association with disease characteristics and pharmacotherapies. Arthritis Rheum. 2008;59: 807-815.
8. Metsios GS, Stavropoulos-Kalinoglou A, Koutedakis Y, Kitas GD. Rheumatoid cachexia: causes, significance and possible interventions. Hosp Chronicles. 2006;1:20-26.
9. Greenberg AS, Nordan RP, McIntosh J, Calvo JC, Scow RO, Jablons D. Interleukin 6 reduces lipoprotein lipase activity in adipose tissue of mice in vivo and in 3T3-L1 adipocytes: a possible role for interleukin 6 in cancer cachexia. Cancer Res. 1992;52:4113-4116.
10. Escalante A, Haas RW, del Rincon I. Paradoxical effect of body mass index on survival in rheumatoid arthritis: role of comorbidity and systemic inflammation. Arch Intern Med. 2005;165:1624-1629.
11. Morley JE. Weight loss in older persons: new therapeutic approaches. Curr Pharm Des. 2007;13:3637-3647.
12. Metsios GS, Stavropoulos-Kalinoglou A, Douglas KMJ, et al. Blockade of tumour necrosis factor-alpha in rheumatoid arthritis: effects on components of rheumatoid cachexia. Rheumatology (Oxford). 2007;46: 1824-1827.
13. DeJong CH, Busquets S, Moses AG, et al. Systemic inflammation correlates with increased expression of skeletal muscle ubiquitin but not uncoupling proteins in cancer cachexia. Oncol Rep. 2005;14: 257-263.
14. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315-324.
15. Prevoo MLL, van't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LBA, van Riel PLCM. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995;38:44-48.
16. Fuchs HA, Brooks RH, Callahan LF, Pincus T. A simplified twentyeight- joint quantitative articular index in rheumatoid arthritis. Arthritis Rheum. 1989;32:531-537.
17. Pincus T, Summey JA, Soraci SA Jr, Wallston KA, Hummon NP. Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire. Arthritis Rheum. 1983;26:1346-1353.
18. Fries JF, Spitz PW, Young DY. The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales. J Rheumatol. 1982;9:789-793.
19. Durnin JV, Womersley J. Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years. Br J Nutr. 1974;32:77-97.
20. Weir JB. New methods for calculating metabolic rate with special reference to protein metabolism. Nutrition. 1990;6:213-221.
21. Elkan AC, Engvall IL, Cederholm T, Höfstrom I. Rheumatoid cachexia, central obesity and malnutrition in patients with low-active rheumatoid arthritis: feasibility of anthropometry, Mini Nutritional Assessment and 40. body composition techniques. Eur J Nutr. 2009;48:315-322.
22. Holland B, Welch AA, Unwin ID, et al. McCance and Widdowson's Composition of Foods, 5th ed. Cambridge: The Royal Society of Chemistry and Ministry of Agriculture, Fisheries and Foods; 1991.
23. Snetselaar LG, Chenard CA, Hunsicker LG, Stumbo PJ. Protein calculation from food diaries of adult humans underestimates values determined using a biological marker. J Nutr. 1995;125: 2333-2340.
24. Ma TS, Zuazaga G. Micro-Kjeldahl determination of nitrogen. A new indicator and an improved rapid method. Ind Eng Chem. 1942;14: 280-282.
25. Holt I, Cooper RG, and Hopkins SJ. Relationships between local inflammation, interleukin-6 concentration and the acute phase protein response in arthritis patients. European Journal of Clinical Investigation. 1991;21:479-484.
26. Engvall IL, Elkan AC, Tengstrand B, Cederholm T, Brismar K, Hafstrom I. Cachexia in rheumatoid arthritis is associated with inflammatory activity, 41. physical disability, and low bioavailable insulinlike growth factor. Scand J Rheumatol. 2008;37:321-328.
27. Pierson RN Jr. Body composition in aging: a biological perspective. Curr Opin Clin Nutr Metab Care. 2003;6:15-20.
28. Book C, Karlsson MK, Akesson K, Jacobsson LT. Early rheumatoid arthritis and body composition. Rheumatology (Oxford). 2009;48: 1128-1132.
29. Clowes GH Jr, George BC, Villee CA Jr, Saravis CA. Muscle proteolysis induced by a circulating peptide in patients with sepsis or trauma. N Engl J Med. 1983;308:545-552.
30. Tocco-Bradley R, Georgieff M, Jones CT, et al. Changes in energy expenditure and fat metabolism in rats infused with interleukin-1. Eur J Clin Invest. 1987;17:504-510.
31. Beck JT, Hsu SM, Wijdenes J, et al. Brief report: alleviation of systemic manifestations of Castleman's disease by monoclonal anti-interleukin-6 antibody. N Engl J Med. 1994;330:602-605.
32. Emilie D, Wijdenes J, Gisselbrecht C, et al. Administration of an anti- interleukin-6 monoclonal antibody to patients with acquired immunodeficiency syndrome and lymphoma: effect on lymphoma growth and on B clinical symptoms. Blood. 1994;84:2472-2479.
33. Stavropoulos-Kalinoglou A. Metsios GS, Panoulas VF, et al. Underweight and obese states both associate with worse disease activity and physical function in patients with established rheumatoid arthritis. Clin Rheumatol. 2009;28:439-444.
34. Barber MD, Fearon KC, Tisdale MJ, McMillan DC, Ross JA. Effect of a fish oil enriched nutritional supplement on metabolic mediators in patients with pancreatic cancer cachexia. Nutr Cancer. 2001;40: 118-124.